GRANULES vs WOCKPHARMA: Stock Comparison

GRANULES INDIA vs WOCKHARDTUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

WOCKHARDT is the larger company by market capitalisation. GRANULES INDIA shows a lower P/E, a higher ROE and a higher dividend yield, while WOCKHARDT shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GRANULES leads 8; WOCKPHARMA leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GRANULESWOCKPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹21,073 Cr
₹33,908 Cr
P/E RatioGRANULES has the lower reading
31.03x
75.68x
P/B RatioGRANULES has the lower reading
4.08x
6.27x
EPSWOCKPHARMA has the higher reading
₹2.9
₹6.58
Book ValueContext only
₹205.21
₹325
Dividend YieldGRANULES has the higher reading
0.21%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹33,908 Cr vs ₹21,073 Cr
P/E Ratio
GRANULES has a lower P/E
31.03x vs 75.68x
P/B Ratio
GRANULES has a lower P/B
4.08x vs 6.27x
EPS
WOCKPHARMA has higher earnings per share
₹6.58 vs ₹2.9
Dividend Yield
GRANULES has a higher dividend yield
0.21% vs 0%
Revenue Growth (TTM YoY)
WOCKPHARMA has faster revenue growth
26% vs 22.8%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs 0%
Qtr Sales Growth
WOCKPHARMA has stronger quarterly sales growth
-39.61% vs -45.7%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESWOCKPHARMA
Live Price₹848.3₹2,088.7
Day Change-0.65%7.08%
Volume11.73 L35.58 L
52-Week High₹910₹2,422.3
52-Week Low₹507.3₹1,086.7
Distance from 52W High-6.78%-13.77%

Valuation

MetricGRANULESWOCKPHARMA
Market Cap₹21,073 Cr₹33,908 Cr
P/E Ratio31.03x75.68x
P/B Ratio4.08x6.27x
EPS₹2.9₹6.58
Book Value₹205.21₹325
Dividend Yield0.21%0%

Growth

MetricGRANULESWOCKPHARMA
Revenue Growth (TTM YoY)22.8%26%
EPS Growth (TTM YoY)31.3%0%
Qtr Sales Growth-45.7%-39.61%
Qtr Profit Growth-60.13%0%

Profitability & Leverage

MetricGRANULESWOCKPHARMA
ROE11.7%10.28%
ROCE12.47%10.37%
Net Margin11.15%3.3%
Operating Margin16.76%28.35%
Debt to Equity0.26x0.57x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGRANULESWOCKPHARMA
Promoter Holding37.67%49.08%
FII Holding17.5% 2.19 pp7.22% 0.13 pp
DII Holding16.11% 0.9 pp9.24% 1.72 pp
Public Holding28.38% 1.28 pp34.44% 1.61 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRANULES INDIA and WOCKHARDT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.